Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fiercebiotech.com

FierceBiotech

Get the latest updates from FierceBiotech directly as they happen.

Follow now 337 followers

Latest posts

Last updated about 8 hours ago

Biomarkers are reshaping oncology trial design

about 8 hours ago

Discover how biomarker strategies are transforming oncology trials and accelerating precision medicine...

Merck unveils PD-1xVEGF bispecific data in NSCLC, remains tight-lipped on phase 3 plans

about 10 hours ago

More than a year after licensing its PD-1xVEGF bispecific, Merck & Co...

UCB pays $650M+ for Neurona, marking 'strategic expansion' into regenerative medicine

about 11 hours ago

The agreement fulfills several ambitions for UCB. Besides building its epilepsy position...

When Spray Drying Falls Short: A Faster Path Forward

about 13 hours ago

Learn how early intervention can help drug developers convert suboptimal formulations into...

3 bioprocessing trends—and the critical enabler that’s quietly driving them

about 14 hours ago

Bioprocessing is evolving rapidly in a shifting landscape of innovative and complex...

Chutes & Ladders—Metsera acquisition architect swings to Structure

about 15 hours ago

After helping guide Metsera through its high-profile, $10 billion acquisition by Pfizer...

OpenAI launches biotech-specific AI model dubbed GPT-Rosalind

about 15 hours ago

Following its recently announced partnership with Novo Nordisk, OpenAI is introducing a...

Abbott lowers EPS guidance on Exact Sciences buy as shares slide

about 16 hours ago

Abbott is dealing with integrating a big new buyout into its business...

Roivant’s CEO thinks China is a ‘red herring’

about 16 hours ago

China’s biotech rise has been a persistent concern for federal health leaders...

A new benchmark for biotech IPOs? Kailera raises $625M to fund obesity pipeline

about 20 hours ago

Kailera Therapeutics appears to have set a new benchmark for biotech IPOs...

Small pools, big ideas: How the rare disease community is reimagining clinical trials

about 22 hours ago

The traditional gold standard of clinical trials with a randomized, placebo-controlled design...

How WuXi AppTec’s Integrated Platform Is Helping Therapies Move Faster from Discovery to Patients

1 day ago

In a complex therapeutic landscape, WuXi AppTec is simplifying the path from...